{"id":"https://openalex.org/W7225309573","doi":"https://doi.org/10.1002/hon.70274","title":"Decision\u2010Making on First\u2010Line Treatment Alternatives in Chronic Lymphocytic Leukemia: A Multi\u2010Criteria Decision Analysis to Elicit Stakeholders' Preferences in Italy","display_name":"Decision\u2010Making on First\u2010Line Treatment Alternatives in Chronic Lymphocytic Leukemia: A Multi\u2010Criteria Decision Analysis to Elicit Stakeholders' Preferences in Italy","publication_year":2026,"publication_date":"2026-11-01","ids":{"openalex":"https://openalex.org/W7225309573","doi":"https://doi.org/10.1002/hon.70274","pmid":"https://pubmed.ncbi.nlm.nih.gov/42985791","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13735206"},"language":"en","primary_location":{"id":"doi:10.1002/hon.70274","doi":"https://doi.org/10.1002/hon.70274","is_oa":true,"landing_page_url":"https://doi.org/10.1002/hon.70274","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hon.70274","source":{"id":"https://openalex.org/S23714410","display_name":"Hematological Oncology","issn_l":"0278-0232","issn":["0278-0232","1099-1069"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematological Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hon.70274","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084332214","display_name":"Paolo Sportoletti","orcid":"https://orcid.org/0000-0002-5630-9862","observed_orcids":["https://orcid.org/0000-0002-5630-9862"]},"institutions":[{"id":"https://openalex.org/I27483092","display_name":"University of Perugia","ror":"https://ror.org/00x27da85","country_code":"IT","type":"education","lineage":["https://openalex.org/I27483092"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Paolo Sportoletti","raw_affiliation_strings":["Dipartmento di Medicina e Chirugia Centro di Ricerca Emato\u2010Oncologica (CREO) Universit\u00e1 di Perugia  Perugia Italy"],"raw_orcid":"https://orcid.org/0000-0002-5630-9862","affiliations":[{"raw_affiliation_string":"Dipartmento di Medicina e Chirugia Centro di Ricerca Emato\u2010Oncologica (CREO) Universit\u00e1 di Perugia  Perugia Italy","institution_ids":["https://openalex.org/I27483092"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061461549","display_name":"Felice Bombaci","orcid":"https://orcid.org/0009-0000-1906-1768","observed_orcids":["https://orcid.org/0009-0000-1906-1768"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Felice Bombaci","raw_affiliation_strings":["AIL Patient Groups  Torino Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AIL Patient Groups  Torino Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037254020","display_name":"Chiara Cernetti","orcid":"https://orcid.org/0000-0002-4457-6605","observed_orcids":["https://orcid.org/0000-0002-4457-6605"]},"institutions":[{"id":"https://openalex.org/I4405263195","display_name":"BeOne Medicines (Switzerland)","ror":"https://ror.org/03saz3d95","country_code":"CH","type":"company","lineage":["https://openalex.org/I4405263195"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Chiara Cernetti","raw_affiliation_strings":["BeOne Medicines Italy Srl  Milan Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BeOne Medicines Italy Srl  Milan Italy","institution_ids":["https://openalex.org/I4405263195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101028748","display_name":"Angelo Costanzo","orcid":"https://orcid.org/0009-0007-5528-138X","observed_orcids":["https://orcid.org/0009-0007-5528-138X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alessandra Di Costanzo","raw_affiliation_strings":["IQVIA Solutions Italy Srl, Real World Solutions  Milan Italy"],"raw_orcid":"https://orcid.org/0009-0007-5528-138X","affiliations":[{"raw_affiliation_string":"IQVIA Solutions Italy Srl, Real World Solutions  Milan Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034318269","display_name":"Francesca Fiorentino","orcid":"https://orcid.org/0000-0003-2092-3593","observed_orcids":["https://orcid.org/0000-0003-2092-3593"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Francesca Fiorentino","raw_affiliation_strings":["IQVIA Solutions Italy Srl, Real World Solutions  Milan Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IQVIA Solutions Italy Srl, Real World Solutions  Milan Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063303113","display_name":"Sara Manurita","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405263195","display_name":"BeOne Medicines (Switzerland)","ror":"https://ror.org/03saz3d95","country_code":"CH","type":"company","lineage":["https://openalex.org/I4405263195"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Sara Manurita","raw_affiliation_strings":["BeOne Medicines Italy Srl  Milan Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BeOne Medicines Italy Srl  Milan Italy","institution_ids":["https://openalex.org/I4405263195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054065835","display_name":"Andrea Marcellusi","orcid":"https://orcid.org/0000-0002-3974-3798","observed_orcids":["https://orcid.org/0000-0002-3974-3798"]},"institutions":[{"id":"https://openalex.org/I189158943","display_name":"University of Milan","ror":"https://ror.org/00wjc7c48","country_code":"IT","type":"education","lineage":["https://openalex.org/I189158943"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Andrea Marcellusi","raw_affiliation_strings":["Department of Pharmaceutical Science University of Milan  Milan Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Science University of Milan  Milan Italy","institution_ids":["https://openalex.org/I189158943"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5093566639","display_name":"Riccardo Mercati","orcid":"https://orcid.org/0009-0001-0873-0193","observed_orcids":["https://orcid.org/0009-0001-0873-0193"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Riccardo Mercati","raw_affiliation_strings":["IQVIA Solutions Italy Srl, Real World Solutions  Milan Italy"],"raw_orcid":"https://orcid.org/0009-0001-0873-0193","affiliations":[{"raw_affiliation_string":"IQVIA Solutions Italy Srl, Real World Solutions  Milan Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050830060","display_name":"Fabio Pammolli A","orcid":"https://orcid.org/0000-0001-7056-1303","observed_orcids":["https://orcid.org/0000-0001-7056-1303","https://orcid.org/0000-0003-4979-8933"]},"institutions":[{"id":"https://openalex.org/I127077003","display_name":"IMT School for Advanced Studies Lucca","ror":"https://ror.org/035gh3a49","country_code":"IT","type":"education","lineage":["https://openalex.org/I127077003"]},{"id":"https://openalex.org/I2800920820","display_name":"Istituto Universitario di Studi Superiori di Pavia","ror":"https://ror.org/0290wsh42","country_code":"IT","type":"education","lineage":["https://openalex.org/I2800920820"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Massimo Riccaboni","raw_affiliation_strings":["AxES IMT School for Advanced Studies  Lucca Italy","IUSS  Pavia Italy"],"raw_orcid":"https://orcid.org/0000-0003-4979-8933","affiliations":[{"raw_affiliation_string":"AxES IMT School for Advanced Studies  Lucca Italy","institution_ids":["https://openalex.org/I127077003"]},{"raw_affiliation_string":"IUSS  Pavia Italy","institution_ids":["https://openalex.org/I2800920820"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062007627","display_name":"Chiara Vassallo","orcid":"https://orcid.org/0000-0001-5811-5992","observed_orcids":["https://orcid.org/0000-0001-5811-5992"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chiara Vassallo","raw_affiliation_strings":["IQVIA Solutions Italy Srl, Real World Solutions  Milan Italy"],"raw_orcid":"https://orcid.org/0000-0001-5811-5992","affiliations":[{"raw_affiliation_string":"IQVIA Solutions Italy Srl, Real World Solutions  Milan Italy","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5062047451","display_name":"Antonio Cuneo","orcid":"https://orcid.org/0000-0003-2001-1308","observed_orcids":["https://orcid.org/0000-0003-2001-1308"]},"institutions":[{"id":"https://openalex.org/I201324441","display_name":"University of Ferrara","ror":"https://ror.org/041zkgm14","country_code":"IT","type":"education","lineage":["https://openalex.org/I201324441"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Antonio Cuneo","raw_affiliation_strings":["Department of Medical Sciences University Hospital of Ferrara  Ferrara Italy"],"raw_orcid":"https://orcid.org/0000-0003-2001-1308","affiliations":[{"raw_affiliation_string":"Department of Medical Sciences University Hospital of Ferrara  Ferrara Italy","institution_ids":["https://openalex.org/I201324441"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5084332214"],"corresponding_institution_ids":["https://openalex.org/I27483092"],"apc_list":{"value":4650,"currency":"USD","value_usd":4650},"apc_paid":{"value":4650,"currency":"USD","value_usd":4650},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.86623883,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"44","issue":"6","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.007600000128149986,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12443","display_name":"Delphi Technique in Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3312","display_name":"Sociology and Political Science"},"field":{"id":"https://openalex.org/fields/33","display_name":"Social Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9990000128746033},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.9039999842643738},{"id":"https://openalex.org/keywords/multi-criteria-decision-making","display_name":"multi-criteria decision making","score":0.8389999866485596},{"id":"https://openalex.org/keywords/stakeholder-preferences","display_name":"stakeholder preferences","score":0.8309999704360962},{"id":"https://openalex.org/keywords/ighv-mutation-status","display_name":"IGHV mutation status","score":0.7770000100135803},{"id":"https://openalex.org/keywords/bruton-tyrosine-kinase-inhibitors","display_name":"BTK inhibitors","score":0.9359999895095825},{"id":"https://openalex.org/keywords/ibrutinib","display_name":"ibrutinib","score":0.8740000128746033},{"id":"https://openalex.org/keywords/acalabrutinib","display_name":"acalabrutinib","score":0.9179999828338623},{"id":"https://openalex.org/keywords/zanubrutinib","display_name":"zanubrutinib","score":1.0},{"id":"https://openalex.org/keywords/venetoclax","display_name":"venetoclax","score":0.9010000228881836},{"id":"https://openalex.org/keywords/obinutuzumab","display_name":"obinutuzumab","score":0.9430000185966492},{"id":"https://openalex.org/keywords/macbeth","display_name":"Macbeth","score":0.7429999709129333},{"id":"https://openalex.org/keywords/treatment-selection-criteria","display_name":"treatment selection criteria","score":0.6240000128746033},{"id":"https://openalex.org/keywords/value-based-decision-making","display_name":"value-based decision making","score":0.6589999794960022}],"concepts":[{"id":"https://openalex.org/C2777609679","wikidata":"https://www.wikidata.org/wiki/Q5971015","display_name":"IGHV@","level":4,"score":0.7329999804496765},{"id":"https://openalex.org/C201305675","wikidata":"https://www.wikidata.org/wiki/Q852998","display_name":"Stakeholder","level":2,"score":0.5863000154495239},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.585099995136261},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.4255000054836273},{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.39259999990463257},{"id":"https://openalex.org/C186116695","wikidata":"https://www.wikidata.org/wiki/Q5249226","display_name":"Decision analysis","level":2,"score":0.38029998540878296},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.37119999527931213},{"id":"https://openalex.org/C11105738","wikidata":"https://www.wikidata.org/wiki/Q1895805","display_name":"Multiple-criteria decision analysis","level":2,"score":0.3671000003814697},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.3537999987602234},{"id":"https://openalex.org/C2781442060","wikidata":"https://www.wikidata.org/wiki/Q425745","display_name":"Bendamustine","level":4,"score":0.3513999879360199},{"id":"https://openalex.org/C2776738588","wikidata":"https://www.wikidata.org/wiki/Q1567856","display_name":"Pharmacoeconomics","level":2,"score":0.33640000224113464},{"id":"https://openalex.org/C150966472","wikidata":"https://www.wikidata.org/wiki/Q3410145","display_name":"Psychosocial","level":2,"score":0.33239999413490295},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.32339999079704285},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.3073999881744385},{"id":"https://openalex.org/C2779263901","wikidata":"https://www.wikidata.org/wiki/Q185916","display_name":"Fludarabine","level":4,"score":0.30090001225471497},{"id":"https://openalex.org/C2780182762","wikidata":"https://www.wikidata.org/wiki/Q1630279","display_name":"Guideline","level":2,"score":0.2676999866962433},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.2669999897480011},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.2662000060081482},{"id":"https://openalex.org/C163763905","wikidata":"https://www.wikidata.org/wiki/Q17075943","display_name":"Precision medicine","level":2,"score":0.2630000114440918},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.2583000063896179},{"id":"https://openalex.org/C31173074","wikidata":"https://www.wikidata.org/wiki/Q2632514","display_name":"Attractiveness","level":2,"score":0.25380000472068787}],"mesh":[{"descriptor_ui":"D003657","descriptor_name":"Decision Making","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D003661","descriptor_name":"Decision Support Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007558","descriptor_name":"Italy","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1002/hon.70274","doi":"https://doi.org/10.1002/hon.70274","is_oa":true,"landing_page_url":"https://doi.org/10.1002/hon.70274","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hon.70274","source":{"id":"https://openalex.org/S23714410","display_name":"Hematological Oncology","issn_l":"0278-0232","issn":["0278-0232","1099-1069"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematological Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13735206","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13735206/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13735206/pdf/HON-44-e70274.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematol Oncol","raw_type":"Text"},{"id":"pmid:42985791","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42985791","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematological oncology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1002/hon.70274","doi":"https://doi.org/10.1002/hon.70274","is_oa":true,"landing_page_url":"https://doi.org/10.1002/hon.70274","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hon.70274","source":{"id":"https://openalex.org/S23714410","display_name":"Hematological Oncology","issn_l":"0278-0232","issn":["0278-0232","1099-1069"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematological Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225309573.pdf","grobid_xml":"https://content.openalex.org/works/W7225309573.grobid-xml"},"referenced_works_count":36,"referenced_works":["https://openalex.org/W1526198513","https://openalex.org/W2036394360","https://openalex.org/W2109508698","https://openalex.org/W2233614027","https://openalex.org/W2239810687","https://openalex.org/W2294402265","https://openalex.org/W2522993795","https://openalex.org/W2670513570","https://openalex.org/W2750036267","https://openalex.org/W2806627663","https://openalex.org/W2902484351","https://openalex.org/W2944141319","https://openalex.org/W2948436219","https://openalex.org/W2954689357","https://openalex.org/W2980619021","https://openalex.org/W2991170682","https://openalex.org/W3016538158","https://openalex.org/W3045571650","https://openalex.org/W3204288598","https://openalex.org/W4205825534","https://openalex.org/W4213453359","https://openalex.org/W4224138250","https://openalex.org/W4233468686","https://openalex.org/W4280503361","https://openalex.org/W4281554396","https://openalex.org/W4293792674","https://openalex.org/W4310065823","https://openalex.org/W4387077974","https://openalex.org/W4387158022","https://openalex.org/W4388405671","https://openalex.org/W4388796333","https://openalex.org/W4391329154","https://openalex.org/W4400298506","https://openalex.org/W4400459887","https://openalex.org/W4401178837","https://openalex.org/W4411321248"],"related_works":["https://openalex.org/W7093123465","https://openalex.org/W7204047949","https://openalex.org/W7213365096","https://openalex.org/W4387158022","https://openalex.org/W2925967061","https://openalex.org/W4399553540","https://openalex.org/W4310125447","https://openalex.org/W4293792674","https://openalex.org/W2750036267","https://openalex.org/W4400459887"],"abstract_inverted_index":{"ABSTRACT":[0],"Chronic":[1],"lymphocytic":[2],"leukemia":[3,11],"(CLL)":[4],"is":[5,297],"the":[6,47,78,133,198,210,215,234,259,269,274,291,298,310],"most":[7,199,270],"common":[8],"form":[9],"of":[10,17,49,80,182,188,293,312],"in":[12,103,118,209,233,306,316],"Western":[13],"countries.":[14],"The":[15,86,114],"introduction":[16],"targeted":[18,90],"therapies":[19,91],"has":[20],"expanded":[21],"first\u2010line":[22,58],"treatment":[23,51,191,230,305,319],"options,":[24],"which":[25],"differ":[26],"across":[27,202],"multiple":[28],"relevant":[29],"dimensions,":[30],"making":[31],"therapeutic":[32],"decisions":[33],"increasingly":[34],"challenging.":[35],"A":[36],"multi\u2010criteria":[37],"decision":[38],"analysis":[39,87],"(MCDA)":[40],"was":[41,116],"conducted":[42],"to":[43,55,143,229,251,303],"identify":[44],"and":[45,54,64,84,101,112,125,157,190,194,246,256,266,284],"quantify":[46],"importance":[48,228],"key":[50],"selection":[52],"criteria":[53,148,176,201],"evaluate":[56],"available":[57],"alternatives":[59],"for":[60,96,123],"patients":[61,238],"with":[62,120,205],"mutated":[63],"unmutated":[65],"immunoglobulin":[66],"heavy\u2010chain":[67],"variable":[68],"region":[69],"(IGHV":[70],"mut":[71,236,261],"/IGHV":[72],"unmut":[73,212,276],")":[74],"gene":[75],"status,":[76],"from":[77,163],"perspective":[79],"clinicians,":[81,167],"patients,":[82,169],"payers,":[83],"methodologists.":[85],"focused":[88],"on":[89,152],"recommended":[92],"by":[93,137],"European":[94],"Society":[95,122],"Medical":[97],"Oncology":[98],"(ESMO)":[99],"guidelines":[100],"reimbursed":[102],"Italy,":[104],"including":[105],"ibrutinib,":[106,111,265],"acalabrutinib,":[107],"zanubrutinib,":[108],"venetoclax":[109,263],"+":[110,264],"venetoclax+obinutuzumab.":[113],"MCDA":[115,300],"developed":[117],"accordance":[119],"International":[121],"Pharmacoeconomics":[124],"Outcomes":[126],"Research":[127],"(ISPOR)":[128],"Good":[129],"Practice":[130],"recommendations,":[131],"using":[132],"MACBETH":[134],"(Measuring":[135],"Attractiveness":[136],"a":[138],"Categorical\u2010Based":[139],"Evaluation":[140],"Technique)":[141],"method":[142],"elicit":[144],"stakeholder":[145,155,222],"preferences.":[146],"Decision":[147],"were":[149,161,177,268],"selected":[150],"based":[151],"literature":[153],"review,":[154],"input,":[156],"data":[158],"availability.":[159],"Preferences":[160],"collected":[162],"20":[164],"stakeholders":[165],"(nine":[166],"five":[168],"six":[170],"payers/methodologists)":[171],"via":[172],"structured":[173],"questionnaires.":[174],"Six":[175],"selected:":[178],"efficacy,":[179],"safety,":[180],"quality":[181],"life":[183],"(QoL),":[184],"drug":[185,252],"cost,":[186],"convenience":[187],"administration,":[189],"duration.":[192],"Efficacy":[193],"safety":[195],"emerged":[196,220],"among":[197],"important":[200],"all":[203],"groups,":[204],"efficacy":[206],"particularly":[207],"prioritized":[208,239],"IGHV":[211,235,260,275],"population.":[213],"Among":[214],"other":[216,243],"criteria,":[217],"notable":[218],"differences":[219],"between":[221],"groups:":[223],"clinicians":[224,255],"assigned":[225],"relatively":[226],"greater":[227],"duration,":[231],"especially":[232],"population;":[237],"QoL":[240],"more":[241,249],"than":[242,254],"groups;":[244],"payers":[245],"methodologists":[247],"gave":[248],"weight":[250],"cost":[253],"patients.":[257],"In":[258,273],"population,":[262,277],"zanubrutinib":[267],"valued":[271],"options.":[272],"second\u2010generation":[278],"Bruton":[279],"tyrosine":[280],"kinase":[281],"inhibitors":[282],"(zanubrutinib":[283],"acalabrutinib)":[285],"ranked":[286],"highest.":[287],"Sensitivity":[288],"analyses":[289],"confirmed":[290],"robustness":[292],"these":[294],"findings.":[295],"This":[296],"first":[299],"study":[301],"applied":[302],"CLL":[304],"Italy.":[307],"It":[308],"highlights":[309],"value":[311],"structured,":[313],"stakeholder\u2010informed":[314],"approaches":[315],"supporting":[317],"value\u2010based":[318],"decisions.":[320]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-11-06T00:00:00"}